Showing results (1-10 of 172) with videos related to

Sort By:
Pageof 18
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 19, 2012
CYP2E1 metabolism of styrene involves allosteryJessica H Hartman, Gunnar Boysen, Grover P Miller
Toxicology|February 25, 2014
Inhibitory potency of 4-carbon alkanes and alkenes toward CYP2E1 activityJessica H Hartman, Grover P Miller, Gunnar Boysen
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 19, 2013
Cooperative effects for CYP2E1 differ between styrene and its metabolitesJessica H Hartman, Gunnar Boysen, Grover P Miller
Toxicology Letters|September 12, 2013
Differences in butadiene adduct formation between rats and mice not due to selective inhibition of CYP2E1 by butadiene metabolitesKaila M Pianalto, Jessica H Hartman, Gunnar Boysen, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 8, 2011
Novel multi-mode ultra performance liquid chromatography-tandem mass spectrometry assay for profiling enantiomeric hydroxywarfarins and warfarin in human plasmaDrew R Jones, Gunnar Boysen, Grover P Miller
Biochemical Pharmacology|December 19, 2013
CYP2E1 hydroxylation of aniline involves negative cooperativityJessica H Hartman, Katie Knott, Grover P Miller
Archives of Biochemistry and Biophysics|December 3, 2014
Multiple UDP-glucuronosyltransferases in human liver microsomes glucuronidate both R- and S-7-hydroxywarfarin into two metabolitesC Preston Pugh, Dakota L Pouncey, Jessica H Hartman, et al.
Drug Metabolism Letters|January 22, 2013
Metabolism of R- and S-warfarin by CYP2C19 into four hydroxywarfarinsSo-Young Kim, Ji-Yeon Kang, Jessica H Hartman, et al.
Toxicology Research|October 10, 2017
Toxicological Implications of Mitochondrial Localization of CYP2E1Jessica H Hartman, Grover P Miller, Joel N Meyer
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 19, 2018
Novel isomeric metabolite profiles correlate with warfarin metabolism phenotype during maintenance dosing in a pilot study of 29 patientsDakota L Pouncey, Jessica H Hartman, Page C Moore, et al.
Pageof 18